Cargando…

Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States

BACKGROUND: Preference valuations of health status are essential in health technology and economic appraisal. This study estimated utilities for treatment-related health states of acute myeloid leukemia (AML) and disutilities of severe adverse events (SAEs) using a representative sample of adults fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stein, Eytan M., Yang, Min, Guerin, Annie, Gao, Wei, Galebach, Philip, Xiang, Cheryl Q., Bhattacharyya, Subrata, Bonifacio, Gaetano, Joseph, George J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151058/ https://www.ncbi.nlm.nih.gov/pubmed/30241538 http://dx.doi.org/10.1186/s12955-018-1013-9

Ejemplares similares

Chronic Myeloid Leukemia: Part I—Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States
por: Atallah, Ehab L., et al.
Publicado: (2022)

Systematic review of health state utility values for acute myeloid leukemia
por: Forsythe, Anna, et al.
Publicado: (2018)

Chronic Myeloid Leukemia: Part II—Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective
por: Atallah, Ehab L., et al.
Publicado: (2022)

Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States
por: Zeidan, Amer M., et al.
Publicado: (2023)

Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States
por: Zeidan, Amer M., et al.
Publicado: (2023)

Treatment patterns and outcomes in BRAF V600E-mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting
por: Gibney, Geoffrey T, et al.
Publicado: (2015)

Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States
por: Medeiros, Bruno C., et al.
Publicado: (2015)

The Cost of Hyperkalemia in the United States
por: Betts, Keith A., et al.
Publicado: (2017)

Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values
por: Round, Jeff, et al.
Publicado: (2017)

Which are the most promising targets for minimal residual disease-directed therapy in acute myeloid leukemia prior to allogeneic stem cell transplant?
por: Ball, Brian, et al.
Publicado: (2019)

An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States
por: Kumar, Vivek, et al.
Publicado: (2018)

Social preferences for health states associated with acute myeloid leukemia for patients undergoing treatment in the United Kingdom
por: Castejón, Nacho, et al.
Publicado: (2018)

Management of Chronic Myeloid Leukemia in Advanced Phase
por: Bonifacio, Massimiliano, et al.
Publicado: (2019)

Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision Analysis
por: Rochau, Ursula, et al.
Publicado: (2015)

Characteristics and survival outcomes of patients with atypical chronic myeloid leukemia in the United States: A SEER-based analysis
por: Ilerhunmwuwa, Nosakhare Paul, et al.
Publicado: (2023)

Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States
por: Sharma, Prateek, et al.
Publicado: (2023)

Variation in Care for Patients with Irritable Bowel Syndrome in the United States
por: Lacy, Brian E., et al.
Publicado: (2016)

Impact of blood count recovery on outcomes of acute myeloid leukemia patients achieving morphologic leukemia-free state
por: Cheng, Wen-Yan, et al.
Publicado: (2018)

The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis
por: Kimball, Alexandra B., et al.
Publicado: (2018)

The societal economic burden of autosomal dominant polycystic kidney disease in the United States
por: Cloutier, Martin, et al.
Publicado: (2020)

CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions
por: Mardiana, Sherly, et al.
Publicado: (2020)

Elicitation of Health State Utility Values in Retinitis Pigmentosa by Time Trade-off in the United Kingdom
por: O’Brien, Paul, et al.
Publicado: (2023)

Prevalence and Characteristics of Telehealth Utilization in the United States
por: Fischer, Shira H., et al.
Publicado: (2020)

Comparative Utilization of Laminoplasty in the United States and Japan
por: H. Waddell, William, et al.
Publicado: (2022)

Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States
por: Shallis, Rory M., et al.
Publicado: (2021)

Numbers and Values of Farm Animals in the United States
Publicado: (1890)

Real-world upper endoscopy utilization patterns among patients with gastroesophageal reflux disease, Barrett esophagus, and Barrett esophagus-related esophageal neoplasia in the United States
por: Sharma, Prateek, et al.
Publicado: (2023)

Utility Values for Advanced Soft Tissue Sarcoma Health States from the General Public in the United Kingdom
por: Guest, Julian F., et al.
Publicado: (2013)

Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom
por: Guest, Julian F, et al.
Publicado: (2014)

The Current State of FLT3 Inhibition in Acute Myeloid Leukemia – Pitfalls and Promises
por: Minson, Katherine A, et al.
Publicado: (2017)

Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges
por: Kang, Synat, et al.
Publicado: (2022)

Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States
por: Abou Dalle, Iman, et al.
Publicado: (2019)

Economic Impact of Transformation to Acute Myeloid Leukemia Among Actively Managed Patients with Higher-Risk Myelodysplastic Syndromes in the United States
por: Kota, Vamsi, et al.
Publicado: (2022)

Impact of agitation in long‐term care residents with dementia in the United States
por: Fillit, Howard, et al.
Publicado: (2021)

Stereotactic radiotherapy of the prostate: fractionation and utilization in the United States
por: P. Weiner, Joseph, et al.
Publicado: (2017)

Trends in Utilization of Transitional Care Management in the United States
por: Marcotte, Leah M., et al.
Publicado: (2020)

Characteristics of antifungal utilization for hospitalized children in the United States
por: Eguiguren, Lourdes, et al.
Publicado: (2022)

Population preference values for health states in relapsed or refractory B-precursor acute lymphoblastic leukemia in the United Kingdom
por: Aristides, Mike, et al.
Publicado: (2015)

Support for Health Insurance Coverage for Legal Abortion in the United States
por: Henderson, Charley, et al.
Publicado: (2021)

Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database
por: Pandya, Bhavik J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a03gorr19gdva3v5464dge40nl